News Wire ~ 3rd Party Press Release

241 POSTS 0 COMMENTS
Nasal Spray

FDA Grants Fast Track Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis

"A significant milestone for INSYS and our clinical development of this novel drug-device combination.”
Auvi-Q

In Response to Shortage, AUVI-Q® Will Be Available in Canada Starting September 7

Interim order by Minister of Health authorizes the importation and sale.
EAT PSA Featuring Jerome Bettis

EAT Launches ‘Give and Go’ Public Service Announcement

PSA will air in movie theaters and online to promote action when anaphylactic reactions occur.
EpiPens

Pfizer Issues Statement Extending the Expiration Date for Select Lots of EpiPen

To address shortages of EpiPen, Pfizer is coordinating with FDA to extend the expiration dates of specific lots of EpiPen® 0.3 mg Auto-Injectors.
Vibex Auto-Injector from Teva partner Antares

FDA Approves First Generic Version of EpiPen

The FDA today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector.
Auvi-Q Manufacturing

Kaléo Confirms US Availability of Auvi-Q Epinephrine Auto-Injector

AUVI-Q is not affected by the manufacturing delays reported to the FDA by other epinephrine auto-injector manufacturers.
Xolair (omalizumab)

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Crayons

Asbestos Found in Popular Crayon Brand

Lab results show many supplies safe, but some contain asbestos, lead and other hazardous chemicals.
PF Goldfish Salmonella

Advisory: Pepperidge Farm Issues Goldfish Recall

Important recall regarding possible salmonella contamination.